Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability and immunogenicity of a potential enteric fever vaccine has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteric Fever

Drugs mentioned

• Enteric fever vaccine (Prokarium)

Snippet

Sponsor: Prokarium Ltd | Conditions: Enteric Fever | Phase 1 | Status: COMPLETED | Results posted: 2025-08-17